Antibacterial Peptide BSN-37 Kills Extra- and Intra-Cellular Salmonella enterica Serovar Typhimurium by a Nonlytic Mode of Action
The increasing rates of resistance to traditional anti-Salmonella agents have made the treatment of invasive salmonellosis more problematic, which necessitates the search for new antimicrobial compounds. In this study, the action mode of BSN-37, a novel antibacterial peptide (AMP) from bovine spleen...
Main Authors: | Lei Yang, Yawei Sun, Yanzhao Xu, Bolin Hang, Lei Wang, Ke Zhen, Bing Hu, Yanan Chen, Xiaojing Xia, Jianhe Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2020.00174/full |
Similar Items
-
Effects of a novel Bacillus subtilis GXYX crude lipopeptide against Salmonella enterica serovar Typhimurium infection in mice
by: Jingya Zhang, et al.
Published: (2024-03-01) -
Changes in Antimicrobial Resistance in Salmonella enterica Serovar Typhimurium
by: Frederick J. Angulo, et al.
Published: (2000-08-01) -
The effect of nitric oxide combined with fluoroquinolones against Salmonella enterica serovar Typhimurium in vitro
by: Coban AY, et al.
Published: (2003-01-01) -
Aquaculture and Florfenicol Resistance in Salmonella enterica Serovar Typhimurium DT104
by: Felipe C. Cabello, et al.
Published: (2009-04-01) -
Prevalence and molecular characterization of Salmonella enterica serovar Typhimurium from ice and beverages in Jakarta, Indonesia
by: Diana E. Waturangi, et al.
Published: (2019-01-01)